Clinical Trial Update: A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety of TD001 in patients with PSMA-expressing metastatic castration-resistant prostate cancer and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• TD001

Snippet

Sponsor: T.O.A.D. Oncology SA | Conditions: Metastatic Castration-Resistant Prostatic Cancer | Phase 1, Phase 2 | Status: RECRUITING